Rapid Detox Treatment Presents Major Risks
Opioid addiction is presenting itself to be a serious public health concern that is steadily on the rise. The CDC has noticed this trend and has issued public notices about the addiction and related information. With rates of opioid addiction increasing, so has the need for detoxification. One practice that many out-patient hospitals are using is called Anesthesia-Assisted Rapid Opioid Detoxification, or AAROD.
According to Medpage Today, AAROD is a procedure that involves the administration of antiemetics drugs, such as clonidine, and antidiarrheal medication that help to reduce the negative side effects of withdrawal and the deliberate induction of withdrawal with high-dose opioid antagonists under a general anesthesia.
These medications are administered through injection or IV while the anesthesia is given through intubation. The anesthesia was administered for a median duration of 8.3 hours, and the median time for administration of the opioid antagonist was 3.9 hours.
New York City Department of Health and Mental Hygiene was alerted by the New York City Poison Control Center for reports of adverse effects of the treatment and an investigation was launched on a particular out-patient clinic.
Between January 2012 and September 2012, 75 patients at this clinic underwent the AAROD treatment.
According to Medpage Today regarding the report:
- Seven patients (9.3%) experienced adverse events that required hospitalization.
- All were men and the median age was 31.
- Four had been taking prescription opioids, two had been taking heroin and opioids, and one used heroin exclusively.
- Two of the affected patients died.
- In one case, the autopsy indicated cardiomegaly and pulmonary edema; in the other, the autopsy revealed anoxic encephalopathy and coronary atherosclerosis, and “hypokalemia and cardiac arrhythmia following anesthesia-assisted rapid opiate detoxification” was the cause of death.
The CDC Recommends Alternative Procedure
The CDC has issued a recommendation for clinics to utilize an alternative detoxification treatment to AAROD. They report that medication-assisted treatment with opioid agonists, such as methadone or buprenorphine, is a safer detoxification treatment to getting patients on the road to recovery.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.